Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLXT

Calyxt (CLXT) Stock Price, News & Analysis

Calyxt logo

About Calyxt Stock (NASDAQ:CLXT)

Advanced Chart

Key Stats

Today's Range
$6.01
$7.77
50-Day Range
$6.30
$31.50
52-Week Range
$1.25
$7.77
Volume
254,056 shs
Average Volume
139,308 shs
Market Capitalization
$31.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Calyxt Completes One-for-Ten Reverse Stock Split
Calyxt Announces Effective Date of Reverse Stock Split
See More Headlines

CLXT Stock Analysis - Frequently Asked Questions

Calyxt, Inc. (NASDAQ:CLXT) issued its quarterly earnings data on Monday, May, 1st. The company reported ($5.45) EPS for the quarter, missing analysts' consensus estimates of ($3.00) by $2.45. The firm had revenue of $0.04 million for the quarter. Calyxt had a negative trailing twelve-month return on equity of 259.69% and a negative net margin of 9,979.64%.

Calyxt's stock reverse split on Thursday, June 1st 2023.The 1-5 reverse split was announced on Thursday, June 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Calyxt (CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calyxt investors own include Cellectis (CLLS), Intel (INTC), Plug Power (PLUG), First Solar (FSLR), Intellia Therapeutics (NTLA), NVIDIA (NVDA) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
5/01/2023
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CLXT
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.89 million
Net Margins
-9,979.64%
Pretax Margin
-9,979.64%

Debt

Sales & Book Value

Annual Sales
$160 thousand
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
11.67

Miscellaneous

Free Float
4,865,000
Market Cap
$31.31 million
Optionable
Not Optionable
Beta
1.98

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CLXT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners